Doctor profile · Federal record
Dr. Lorraine Calvert, NP
Adult Health Nurse Practitioner (CMS: Nurse Practitioner) · Indianapolis, IN
- NPI 1730166778
- Accepts Medicare
- 37 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
8435 Clearvista Place, Suite 101
Indianapolis, IN 46256
(317) 621-1006
fax (317) 621-1011 - Additional location
-
3125 S Scatterfield RD Ste 310
Anderson, IN 460131804
fax (317) 355-6822 - Mailing address
-
6626 E 75Th St, Suite 500
Indianapolis, IN 462502805
Credentials & registration
- NPI registered
- December 2005 — 21 yrs on file
- Profile last updated
- June 10, 2021
- Year of graduation
- 1989 — 37 yrs since
- Specialty taxonomy
- 363LA2200X — NUCC code
- State license (1)
- Indiana #71000034A
- Medicaid
- IN #200066260
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1730166778. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
48,940
Distinct HCPCS
6
Medicare allowed
$615,429
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3111 |
Injection, romosozumab-aqqg, 1 mg | 41,160 | 31 | $10 | |
J0897 |
Injection, denosumab, 1 mg | 7,080 | 76 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 321 | 231 | $101 | |
96372 |
Injection of drug or substance under skin or into muscle | 314 | 100 | $11 | |
83036 |
Hemoglobin a1c level | 45 | 39 | $10 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 20 | 19 | $141 |
In context: peer comparison
Among 39 peers in this city , average services per provider: 374. This provider delivers 131× the peer median.Open Payments
Industry payments received
All-time total
$1,794
Transactions
84
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 17 | $280.63 | |
| Radius Health, Inc. | 10 | $161.23 | |
| Medtronic, Inc. | 12 | $151.19 | |
| Abbott Laboratories | 3 | $136.96 | |
| ABBVIE INC. | 6 | $112.15 | |
| Corcept Therapeutics | 5 | $99.89 | |
| Tandem Diabetes Care, Inc. | 3 | $91.91 | |
| Novartis Pharmaceuticals Corporation | 3 | $87.10 | |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $85.27 | |
| SANOFI-AVENTIS U.S. LLC | 4 | $79.96 | |
| Amgen Inc. | 4 | $74.26 | |
| Novo Nordisk Inc | 4 | $71.95 | |
| Alexion Pharmaceuticals, Inc. | 4 | $68.37 | |
| Dexcom, Inc. | 3 | $65.70 | |
| Astellas Pharma US Inc | 2 | $43.28 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,114
Patients
291
Total drug cost
$955,854
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 125 | 32 | $103,814 |
| Levothyroxine Sodium | Generic | 122 | 35 | $1,718 |
| Ozempic (Semaglutide) | Brand | 116 | 27 | $153,964 |
| Synthroid (Levothyroxine Sodium) | Brand | 92 | 21 | $7,865 |
| Forteo (Teriparatide) | Brand | 91 | 0 | $421,343 |
| Atorvastatin Calcium | Generic | 88 | 28 | $898 |
| Nano 2nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 84 | 38 | $7,277 |
| Humalog Kwikpen U-100 (Insulin Lispro) | Brand | 67 | 18 | $63,286 |
| Trulicity (Dulaglutide) | Brand | 54 | 15 | $80,169 |
| Lisinopril | Generic | 51 | 12 | $145 |
Frequently asked questions
What is Dr. Lorraine Calvert's medical specialty?
Dr. Lorraine Calvert practices Adult Health Nurse Practitioner in Indianapolis, IN.
Where does Dr. Lorraine Calvert practice?
Dr. Lorraine Calvert practices at 8435 Clearvista Place, Indianapolis, IN 46256. Office phone: 3176211006.
What is Dr. Lorraine Calvert's NPI?
Dr. Lorraine Calvert's National Provider Identifier (NPI) is 1730166778, issued by NPPES.
Does Dr. Lorraine Calvert accept Medicare assignment?
Yes. Dr. Lorraine Calvert accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Lorraine Calvert commonly perform?
Top Medicare-reported procedures in 2023: Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.